Torbjørn Wisløff, MSc, PhD
Oslo University Hospital & University of Oslo
Postboks 1089 Blindern
Oslo
Norway
0317
Papers:
1C-2
COST-EFFECTIVENESS OF ANTIPLATELET DRUGS AFTER PERCUTANEOUS CORONARY INTERVENTION
COMPARATIVE EFFECTIVENESS AND COST EFFECTIVENESS OF GENERIC ALENDRONATE, RISEDRONATE, DENOSUMAB AND ZOLEDRONIC ACID FOR SECONDARY PREVENTION OF FRAGILITY FRACTURES- PRELIMINARY RESULTS
ECONOMIC EVALUATION OF COMBINATION TREATMENTS – DOES USE OF NETWORK META-ANALYSIS MAKE A DIFFERENCE?